A phase III randomised controlled trial of erlotinib vs gefitinib in advanced non-small cell lung cancer with EGFR mutations
British Journal of Cancer advance online publication, January 19 2017. doi:10.1038/bjc.2016.456
Authors: J J Yang, Q Zhou, H H Yan, X C Zhang, H J Chen, H Y Tu, Z Wang, C R Xu, J Su, B C Wang, B Y Jiang, X Y Bai, W Z Zhong, X N Yang & Y L Wu
from #AlexandrosSfakianakis via Alexandros G.Sfakianakis on Inoreader http://ift.tt/2k6t2N3
via IFTTT
Δεν υπάρχουν σχόλια:
Δημοσίευση σχολίου